DiaMonTech GmbH, a young medical technology company, has received the CE certification for its first medical product "DMT Base". The device enables non-invasive blood glucose measurement using laser-based technology. The certification confirms that the patented technology meets the high safety and performance standards for medical devices required for market approval. The label is valid for all countries of the European Union.

"The CE label of our non-invasive blood glucose monitoring device is an important milestone for our company. It is backed by more than 20 years of intensive research and development work. Now our goal is to make this technology available to as many diabetes patients and as quickly as possible, thereby making their lives easier," says Thorsten Lubinski, co-founder and CEO of DiaMonTech GmbH.

The "DMT Base" can be used intuitively: the patient places his finger on a sensor field for a few seconds and the blood sugar level is shown on a display. The blood sugar level can thus be measured precisely and painlessly without a drop of blood. The measurement can be carried out as often as desired without consumables (test strips). For the user, the need to prick several times a day is eliminated.

The "DMT Base" is currently optimised for use in professional environments (e.g. diabetes centres). The smaller "DMT Pocket" is currently under development. This device is intended to be about the size of a smartphone and could therefore be a constant companion for diabetes patients.